Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check2 days agoChange DetectedRevision tag on the study record page updated from v3.5.4 to v3.5.5. This update reflects a minor page revision and does not alter trial data, eligibility criteria, or displayed results.SummaryDifference0.0%

- Check9 days agoChange DetectedA Publications section was added to the Study Details page, including the citation for the Phase 3 Treprostinil in IPF publication and a note that publications are automatically filled from PubMed.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page shows an updated revision tag to v3.5.4, replacing the previous revision v3.5.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe study's location count was updated to 98 locations, and the Franklin, TN site (Clinical Trials Center of Middle Tennessee) was removed from the list, reflecting a revision of active trial sites as of the May 2026 update.SummaryDifference0.2%

- Check38 days agoChange DetectedPage revision label updated from v3.5.2 to v3.5.3 in the site’s versioning metadata. This indicates a new revision of the page, but it does not alter the study data or content visible to users.SummaryDifference0.0%

- Check45 days agoChange DetectedUpdated language and related resource/location text for Valparaiso, Chile (including regional wording) and refreshed the displayed site/release revision from v3.5.0 to v3.5.2.SummaryDifference0.3%

Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.